Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1994 Oct;72(4):349–353. doi: 10.1136/hrt.72.4.349

Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid.

I Ostman-Smith 1, G Brown 1, A Johnson 1, J M Land 1
PMCID: PMC1025545  PMID: 7833193

Abstract

A case of dilated cardiomyopathy in a young boy secondary to type II 3-methylglutaconic aciduria is described. A metabolic cause for his dilated cardiomyopathy was suspected because of the development on the electrocardiogram of an unusual "camel's hump" shape of the T waves, and of progressive thickening with increasing echogenicity of the left ventricular wall. He initially improved on digoxin treatment, but did not maintain the response with conventional dietary treatment for this condition. Supplementation with L-carnitine was associated with rapid deterioration in cardiac state, and may be contraindicated in this condition. At a point when the patient was moribund, large doses of pantothenic acid, a precursor of coenzyme A, produced a dramatic and sustained improvement in myocardial function and in growth, neutrophil cell count, hypocholesterolaemia, and hyperuricaemia, which suggests that limitation of availability of coenzyme A is a fundamental pathological process in this condition. The clinical improvement has been maintained for 13 months, and myocardial function is now nearly normal. Oral pantothenol, unlike pantothenic acid, is not efficacious.

Full text

PDF
349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Devereux R. B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977 Apr;55(4):613–618. doi: 10.1161/01.cir.55.4.613. [DOI] [PubMed] [Google Scholar]
  2. Fox I. H., Palella T. D., Kelley W. N. Hyperuricemia: a marker for cell energy crisis. N Engl J Med. 1987 Jul 9;317(2):111–112. doi: 10.1056/NEJM198707093170209. [DOI] [PubMed] [Google Scholar]
  3. Fry P. C., Fox H. M., Tao H. G. Metabolic response to a pantothenic acid deficient diet in humans. J Nutr Sci Vitaminol (Tokyo) 1976;22(4):339–346. doi: 10.3177/jnsv.22.339. [DOI] [PubMed] [Google Scholar]
  4. Kelley R. I., Cheatham J. P., Clark B. J., Nigro M. A., Powell B. R., Sherwood G. W., Sladky J. T., Swisher W. P. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr. 1991 Nov;119(5):738–747. doi: 10.1016/s0022-3476(05)80289-6. [DOI] [PubMed] [Google Scholar]
  5. RALLI E. P., DUMM M. E. Relation of pantothenic acid to adrenal cortical function. Vitam Horm. 1953;11:133–158. doi: 10.1016/s0083-6729(08)61097-3. [DOI] [PubMed] [Google Scholar]
  6. Stanley C. A. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv Pediatr. 1987;34:59–88. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES